Year 2014 has provided insight into the optimal care of surgical patients with cardiovascular disease. In mitral disease, the management of degenerative mitral regurgitation and ischemic mitral insufficiency are moving in the opposite directions. In aortic disease, the description of arch procedures is becoming more definable for comparisons across approaches, while the treatment of acute type B dissections is becoming more aggressive, yet deliberate.
SuriRMVanoverscheldeJLGrigioniF. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA. 2013;310:609-616.
2.
SmithPKPuskasJDAscheimDD. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178-2188.
3.
YanTDBannonPGBavariaJ. Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg. 2013;2:163-168.
4.
YanTDTianDHLemaireSA; International Aortic Arch Surgery Study Group. Standardizing clinical end points in aortic arch surgery: a consensus statement from the International Aortic Arch Surgery Study Group. Circulation. 2014;129:1610-1616.
5.
NienaberCAKischeSAkinI. Strategies for subacute/chronic type B aortic dissection: the Investigation Of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg. 2010;140(6 suppl):S101-S108.
6.
NienaberCAKischeSRousseauH; INSTEAD-XL Trial. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv. 2013;6:407-416.
